Mielóma multiplex: vizsgálatok itt: Kína
204 trials · From ClinicalTrials.gov, checked 2026. november 16.. Ask the study team whether a trial fits you.
- 3. fázisNot yet taking people in KínaClinical Study of TQB2934 Injection in Relapsed/Refractory Multiple Myeloma
- Where
- Beijing, Bengbu, Binzhou, Cangzhou, Changsha, Changzhi, Chengde, Chengdu, Chongqing, Guangzhou, Guiyang, Hangzhou, Harbin, Hefei, Jinan, Jining, Kunming, Lanzhou, Luoyang, Luzhou, Nanchang, Nanjing, Nanning, Ningbo, Qingdao, Shanghai, Shenyang, Shijiazhuang, Taiyuan, Tianjin, Ürümqi, Xi'an, Xi’an, Xuzhou, Zhanjiang, Zhengzhou, Zhuzhou
- Életkor
- 18 év to 75 év
- People
- 260
- Run by
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07569757 - 3. fázisTaking peopleA Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
- Where
- Beijing, Chengdu, Chongqing, Guangzhou, Hangzhou, Nanchang, Nanjing, Shanghai, Shanghia, Shenzhen, Tianjin, Wenzhou, Xi'an
- Életkor
- 18 év and over
- People
- 520 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06679101 · EU 2024-516030-35-00 - Korai 1. fázisNot yet taking people in KínaA Clinical Study to Evaluate the Safety and Preliminary Efficacy of QI-019B in Patients With Relapsed/Refractory Multiple Myeloma.
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 24
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07539233 - 1. fázisNot yet taking people in KínaBR101 in Patients With Relapsed/Refractory Multiple Myeloma
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 10
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07537049 - Korai 1. fázisTaking peoplePET Imaging Study of 68Ga-NB381 in Multiple Myeloma
- Where
- Beijing
- Életkor
- 18 év to 90 év
- People
- 30
- Run by
- Peking University First Hospital
See details and how to joinNCT06385652 - 1. fázisTaking peopleA Clinical Study of SHR-9539 in Patients With Multiple Myeloma
- Where
- Chengdu
- Életkor
- 18 év and over
- People
- 138
- Run by
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
See details and how to joinNCT06484777 - 1. fázisTaking peopleStudy to Assess Safety and Efficacy of HDP-101 in Chinese Patients With Relapsed or Refractory Multiple Myeloma
- Where
- Beijing, Hangzhou, Jinan, Suzhou, Tianjin
- Életkor
- Up to 18 év
- People
- 15
- Run by
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
See details and how to joinNCT07529782 - 1/2. fázisTaking peopleAdaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies
- Where
- Shenzhen
- Életkor
- 18 év to 75 év
- People
- 96
- Run by
- Beijing Biotech
See details and how to joinNCT07523555 - No phaseTaking peoplePredicting Response to Selinexor-Based Therapy in Relapsed/Refractory Multiple Myeloma: A Multicenter Prospective Study
- Where
- Taiyuan
- Életkor
- 18 év and over
- People
- 127
- Run by
- Shanxi Bethune Hospital
See details and how to joinNCT07514052 - No phaseTaking peopleDara-PD in the Treatment of Patients With First Relapse of Multiple Myeloma
- Where
- Changchun
- Életkor
- 18 év and over
- People
- 50
- Run by
- FengYan Jin
See details and how to joinNCT06252792 - 2. fázisTaking peopleIL-15-Armored CAR-T Therapy in Relapsed or Refractory Multiple Myeloma and Plasma Cell Leukemia
- Where
- Changchun
- Életkor
- 18 év to 80 év
- People
- 25
- Run by
- The First Hospital of Jilin University
See details and how to joinNCT07509086 - No phaseTaking peopleEpunamin Combined With DECP for Relapsed/Refractory Multiple Myeloma
- Where
- Taiyuan
- Életkor
- 18 év to 75 év
- People
- 48
- Run by
- Shanxi Bethune Hospital
See details and how to joinNCT07497165 - 3. fázisTaking peopleA Study of GR1803 Injection Versus Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Participants With Relapsed or Refractory Multiple Myeloma
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 358
- Run by
- Genrix (Shanghai) Biopharmaceutical Co., Ltd.
See details and how to joinNCT07452198 - 2. fázisTaking peopleStudy of PD-1Ab21-BCMA CAR-T Therapy for Consolidation of Multiple Myelomawith Renal Dysfunction
- Where
- Beijing
- Életkor
- 14 év and over
- People
- 25
- Run by
- Daihong Liu
See details and how to joinNCT07489534 - 1/2. fázisTaking peopleClinical Study on the Safety and Efficacy of BCMA-CART±ASCT in Treating Young Multiple Myeloma Patients
- Where
- Tianjin
- Életkor
- 18 év to 50 év
- People
- 50
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07169500 - 1/2. fázisTaking peopleA Study of GC012F in Patients With Relapsed/Refractory Multiple Myeloma
- Where
- Beijing, Hangzhou, Jinan, Shanghai, Shenyang, Wenzhou, Wuhan, Xi'an
- Életkor
- 18 év to 75 év
- People
- 110
- Run by
- Gracell Biotechnologies (Shanghai) Co., Ltd.
See details and how to joinNCT06235229 - 1/2. fázisTaking peopleBiomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors
- Where
- Beijing
- Életkor
- 8 év to 85 év
- People
- 85
- Run by
- Essen Biotech
See details and how to joinNCT07410494 - 3. fázisTaking peoplePrevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen
- Where
- Ningbo
- Életkor
- 18 év to 65 év
- People
- 92
- Run by
- The Affiliated People's Hospital of Ningbo University
See details and how to joinNCT07413809 - No phaseCsak meghívásosAI-Based Fine Morphological Subtyping of Myeloma Single Cells for Predicting FISH Abnormalities
- Where
- Wuhan
- People
- 10
- Run by
- Fuling Zhou
See details and how to joinNCT07410403 - No phaseTaking peopleNational Longitudinal Cohort of Hematological Diseases
- Where
- Tianjin
- People
- 2300
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT04645199 - No phaseTaking peopleIndividualized Dynamic Frailty-tailored Therapy (DynaFiT) in Elderly Patients With NDMM
- Where
- Changchun
- Életkor
- 65 év and over
- People
- 131
- Run by
- FengYan Jin
See details and how to joinNCT06099912 - Korai 1. fázisNot yet taking people in KínaA Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Multiple Myeloma(LB2505-0001)
- Where
- Beijing, Nanchang, Tianjin, Wuhan, Xuzhou, Zhengzhou
- Életkor
- 18 év and over
- People
- 38
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07399444 - 1. fázisTaking peopleA Study of YKST02 in Participants With Relapsed or Refractory Multiple Myeloma
- Where
- Beijing, Dalian, Foshan, Guangzhou, Hangzhou, Harbin, Jinan, Nanning, Taiyuan, Zhengzhou
- Életkor
- 18 év to 75 év
- People
- 70
- Run by
- Excyte Biopharma Ltd
See details and how to joinNCT06574568 - 3. fázisTaking peopleA Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 292
- Run by
- Sinocelltech Ltd.
See details and how to joinNCT07297329 - No phaseNot yet taking people in KínaA Clinical Study Evaluating the Safety and Efficacy of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Have Received Three or More Lines of Treatment
- Where
- Wuhan
- Életkor
- 18 év to 78 év
- People
- 28
- Run by
- Donghua Zhang
See details and how to joinNCT07376720